Learn more

ALLERGAN PHARMA

Overview
  • Total Patents
    161
About

ALLERGAN PHARMA has a total of 161 patent applications. Its first patent ever was published in 1962. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, basic materials chemistry and medical technology are OPHTECS CORP, THR DIAL CORP and EBIOX LTD.

Patent filings per year

Chart showing ALLERGAN PHARMAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kiral Richard M 12
#2 Huth Stanley W 12
#3 Lam Sam W 11
#4 Boghosian Malcolm P 9
#5 Takruri Harun 8
#6 Mirejovsky Dorla 8
#7 Thompson Shurl A 7
#8 Park John Y 7
#9 Kleist Frederick D 6
#10 Karageozian Hampar L 4

Latest patents

Publication Filing date Title
US4790846A Haptic to optic attachment for a soft IOL
EP0278040A1 Use of pteridines and/or purines or of a xanthineoxidase inhibitor for the preparation of a medicament for the treatment of hereditary degenerative retinal diseases
EP0208546A2 IOL and method of attaching a fixation member to an optic
IL79114D0 Method and composition for making liposomes
US4670178A Method for the simultaneous cleaning and disinfecting of contact lenses
IE851458L Transdermal and transmembrane compositions
US4743588A Compositions and methods of enhancing transdermal and transmembrane penetration systemic agents
IE841333L Stabilizing thimerosal
US4524063A Ophthalmic compositions
US4460573A Methods of stabilizing thimerosal in presence of polyvinylpyrrolidone
US4395346A Method for cleaning contact lenses
NZ192499A Treatment of contact lenses with polymetaphosphate gluconic acid or borogluconic acid
US4255419A Zinc deficiency in multiple sclerosis
US4230724A Method of treating vascularization of the eye with Flurbiprofen
US4244948A Medical use of esters of acetylsalicylic acid to treat acne
JPS5573609A Local and ophthalmic composition and its use
DE2851281A1 Human glaucoma treatment with labetalol - which is an amino- and hydroxyalkyl substd. salicylamide
GB2033222A Topical Ophthalmic Composition
US4197301A Topical ophthalmic use of Prazosin
US4155738A Method of stabilizing a peroxide-containing composition